Charles G Drake


Ontology type: schema:Person     


Person Info

NAME

Charles G

SURNAME

Drake

Publications in SciGraph latest 50 shown

  • 2018-10 Absence of host NF-κB p50 induces murine glioblastoma tumor regression, increases survival, and decreases T-cell induction of tumor-associated macrophage M2 polarization in CANCER IMMUNOLOGY, IMMUNOTHERAPY
  • 2018-09 Immunotherapy in Prostate Cancer: Teaching an Old Dog New Tricks in CURRENT ONCOLOGY REPORTS
  • 2018-08 Combined local and systemic attacks in NATURE BIOMEDICAL ENGINEERING
  • 2018-04 Combining intratumoral Treg depletion with androgen deprivation therapy (ADT): preclinical activity in the Myc-CaP model in PROSTATE CANCER AND PROSTATIC DISEASES
  • 2018-04 Combining immune check-point blockade and cryoablation in an immunocompetent hormone sensitive murine model of prostate cancer in PROSTATE CANCER AND PROSTATIC DISEASES
  • 2017-12 New Cancer Immunotherapy Agents in Development: a report from an associated program of the 31stAnnual Meeting of the Society for Immunotherapy of Cancer, 2016 in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2017-03 Correlation of B7-H3 with androgen receptor, immune pathways and poor outcome in prostate cancer: an expression-based analysis in PROSTATE CANCER AND PROSTATIC DISEASES
  • 2016-12 The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of prostate carcinoma in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2016-12 Erratum to: Agonist anti-GITR monoclonal antibody and stereotactic radiation induce immune-mediated survival advantage in murine intracranial glioma in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2016-12 Agonist anti-GITR monoclonal antibody and stereotactic radiation induce immune-mediated survival advantage in murine intracranial glioma in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2016-08 Blood Transfusion is Associated with Increased Perioperative Morbidity and Adverse Oncologic Outcomes in Bladder Cancer Patients Receiving Neoadjuvant Chemotherapy and Radical Cystectomy in ANNALS OF SURGICAL ONCOLOGY
  • 2016-07 Melanoma and immunotherapy bridge 2015 in JOURNAL OF TRANSLATIONAL MEDICINE
  • 2016-01 Immune checkpoint inhibitors: a new frontier in bladder cancer in WORLD JOURNAL OF UROLOGY
  • 2015-12 Paucity of PD-L1 expression in prostate cancer: innate and adaptive immune resistance in PROSTATE CANCER AND PROSTATIC DISEASES
  • 2015-12 Agonist anti-GITR monoclonal antibody and stereotactic radiation induce immune-mediated survival advantage in murine intracranial glioma in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2015-12 Markers of inflammation are associated with clinical outcomes in patients with metastatic renal cell carcinoma treated with nivolumab in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2015-12 Immune biomarkers associated with clinical benefit from atezolizumab (MPDL3280a; anti-PD-L1) in advanced urothelial bladder cancer (UBC) in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2015-12 A multi-omic analysis of human naïve CD4+ T cells in BMC SYSTEMS BIOLOGY
  • 2015-12 Cyclic dinucleotides (CDNs) reversed T cells tolerance in anti-tumor immunotherapy in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2015-12 Immune response from STRIDE, a randomized, Phase II, open-label study of sipuleucel-T (sip-T) with concurrent vs sequential enzalutamide (enz) administration in metastatic castration-resistant prostate cancer (mCRPC) in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2015-09 Pre-radiation lymphocyte harvesting and post-radiation reinfusion in patients with newly diagnosed high grade gliomas in JOURNAL OF NEURO-ONCOLOGY
  • 2015-09 Intraprostatic inflammation is positively associated with serum PSA in men with PSA <4 ng ml−1, normal DRE and negative for prostate cancer in PROSTATE CANCER AND PROSTATIC DISEASES
  • 2015 Immune Checkpoint Inhibition in Renal Cell Carcinoma in KIDNEY CANCER
  • 2014-12 Tumor immunology and cancer immunotherapy: summary of the 2013 SITC primer in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2014-12 Harnessing the PD-1 Pathway in Renal Cell Carcinoma: Current Evidence and Future Directions in BIODRUGS
  • 2014-10 Metastatic castration-resistant prostate cancer: new therapies, novel combination strategies and implications for immunotherapy in ONCOGENE
  • 2014-09 Immunotherapy for prostate cancer: recent developments and future challenges in CANCER AND METASTASIS REVIEWS
  • 2014-06 Reply: Regulatory T cells—an important target for cancer immunotherapy in NATURE REVIEWS CLINICAL ONCOLOGY
  • 2014-01 Breathing new life into immunotherapy: review of melanoma, lung and kidney cancer in NATURE REVIEWS CLINICAL ONCOLOGY
  • 2013-12 Sequencing CTLA-4 blockade with cell-based immunotherapy for prostate cancer in JOURNAL OF TRANSLATIONAL MEDICINE
  • 2013-11 Expression of neuropilin-1 on in vivo induced regulatory T cells in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2012-03 The composition and signaling of the IL-35 receptor are unconventional in NATURE IMMUNOLOGY
  • 2011-11 Resolution of infection promotes a state of dormancy and long survival of CD4 memory T cells in IMMUNOLOGY AND CELL BIOLOGY
  • 2010-11-18 LAG-3 in Cancer Immunotherapy in CANCER IMMUNOLOGY AND IMMUNOTHERAPY
  • 2010-08 Prostate cancer as a model for tumour immunotherapy in NATURE REVIEWS IMMUNOLOGY
  • 2010-06 Intra-individual variation in serum C-reactive protein over 4 years: an implication for epidemiologic studies in CANCER CAUSES & CONTROL
  • 2010-05 Update: Immunological Strategies for Prostate Cancer in CURRENT UROLOGY REPORTS
  • 2007-04 Inflammation in prostate carcinogenesis in NATURE REVIEWS CANCER
  • 2005-07 Erratum: Egr-2 and Egr-3 are negative regulators of T cell activation in NATURE IMMUNOLOGY
  • 2005-05 Egr-2 and Egr-3 are negative regulators of T cell activation in NATURE IMMUNOLOGY
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "affiliation": [
          {
            "affiliation": {
              "id": "https://www.grid.ac/institutes/grid.21107.35", 
              "type": "Organization"
            }, 
            "isCurrent": true, 
            "type": "OrganizationRole"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.239585.0", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.420086.8", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.65499.37", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.411935.b", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.419971.3", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.412726.4", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.239864.2", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.21729.3f", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.488747.0", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.413734.6", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.4367.6", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.469474.c", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.240871.8", 
            "type": "Organization"
          }
        ], 
        "familyName": "Drake", 
        "givenName": "Charles G", 
        "id": "sg:person.014571064077.28", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014571064077.28"
        ], 
        "sdDataset": "persons", 
        "sdDatePublished": "2019-03-07T13:34", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-uberresearch-data-dimensions-researchers-20181010/20181011/dim_researchers/base/researchers_1362.json", 
        "type": "Person"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/person.014571064077.28'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/person.014571064077.28'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/person.014571064077.28'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/person.014571064077.28'


     

    This table displays all metadata directly associated to this object as RDF triples.

    42 TRIPLES      10 PREDICATES      24 URIs      7 LITERALS      2 BLANK NODES

    Subject Predicate Object
    1 sg:person.014571064077.28 schema:affiliation N4ef203be43784eafb32dc8a8843f3f04
    2 https://www.grid.ac/institutes/grid.21729.3f
    3 https://www.grid.ac/institutes/grid.239585.0
    4 https://www.grid.ac/institutes/grid.239864.2
    5 https://www.grid.ac/institutes/grid.240871.8
    6 https://www.grid.ac/institutes/grid.411935.b
    7 https://www.grid.ac/institutes/grid.412726.4
    8 https://www.grid.ac/institutes/grid.413734.6
    9 https://www.grid.ac/institutes/grid.419971.3
    10 https://www.grid.ac/institutes/grid.420086.8
    11 https://www.grid.ac/institutes/grid.4367.6
    12 https://www.grid.ac/institutes/grid.469474.c
    13 https://www.grid.ac/institutes/grid.488747.0
    14 https://www.grid.ac/institutes/grid.65499.37
    15 schema:familyName Drake
    16 schema:givenName Charles G
    17 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014571064077.28
    18 schema:sdDatePublished 2019-03-07T13:34
    19 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    20 schema:sdPublisher N0611d8bd5ec54e1b87239cb9839e56a0
    21 sgo:license sg:explorer/license/
    22 sgo:sdDataset persons
    23 rdf:type schema:Person
    24 N0611d8bd5ec54e1b87239cb9839e56a0 schema:name Springer Nature - SN SciGraph project
    25 rdf:type schema:Organization
    26 N4ef203be43784eafb32dc8a8843f3f04 schema:affiliation https://www.grid.ac/institutes/grid.21107.35
    27 sgo:isCurrent true
    28 rdf:type schema:OrganizationRole
    29 https://www.grid.ac/institutes/grid.21107.35 schema:Organization
    30 https://www.grid.ac/institutes/grid.21729.3f schema:Organization
    31 https://www.grid.ac/institutes/grid.239585.0 schema:Organization
    32 https://www.grid.ac/institutes/grid.239864.2 schema:Organization
    33 https://www.grid.ac/institutes/grid.240871.8 schema:Organization
    34 https://www.grid.ac/institutes/grid.411935.b schema:Organization
    35 https://www.grid.ac/institutes/grid.412726.4 schema:Organization
    36 https://www.grid.ac/institutes/grid.413734.6 schema:Organization
    37 https://www.grid.ac/institutes/grid.419971.3 schema:Organization
    38 https://www.grid.ac/institutes/grid.420086.8 schema:Organization
    39 https://www.grid.ac/institutes/grid.4367.6 schema:Organization
    40 https://www.grid.ac/institutes/grid.469474.c schema:Organization
    41 https://www.grid.ac/institutes/grid.488747.0 schema:Organization
    42 https://www.grid.ac/institutes/grid.65499.37 schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...